None
DE
Biomea Fusion, Inc.: Biomea Fusion Announces First Patient Dosed in OPAL Study Evaluating Icovamenib in Combination with Semaglutide in Obesity
['Globenewswire', 'Europe']
FinanzNachrichten.de: News
Established through a strategic partnership between the University Hospitals of Leicester National Health Service (NHS) Trust and the University of Leicester, the LDC facilitates a unique synergy between NHS clinicians, clinical researchers, and academic investigators within the University of Leicester Diabetes Research Centre. The National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) Leicester is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester, Loughborough University and the University Hospitals of Northamptonshire NHS Group.